Here you can find press releases, news, prospectus, presentations and financial reports about Immunovia AB. Additionally, we have included information about the share, the owners, insider trading, calendar and financial situation.

If you have further questions, please contact our IR contact.

If you are interested to receive our press releases and reports, please click on “Subscribe”.

The Immunovia AB share is since December 1, 2015, traded on Nasdaq Stockholm First North (ticker: IMMNOV).

Important Information about First North
First North is an alternative marketplace operated by an exchange within the Nasdaq group. Companies on First North are not subject to the same rules as companies on the regulated main market. Instead they are subject to a less extensive set of rules and regulations adjusted to small growth companies. The risk in investing in a Company on First North may therefore be higher than investing in a company on the main market. All Companies with shares traded on First North have a Certified Adviser who monitors that the rules are followed. The Exchange approves the application for admission to trading.

Immunovia General Meeting, April 25, 2017

Link to documents for the General Meeting and Proxy form


Shareholder Newsletters

Shareholder Newsletter, Q4 2016 (PDF in English)

Nyhetsbrev till aktieägare, Q4 2016 (PDF in Swedish)


CEO summarizes year 2015 in this first shareholder newsletter.

Shareholder Newsletter (PDF in English)

Nyhetsbrev till aktieägare (PDF in Swedish)